| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | HALOZYME THERAPEUTICS, INC. | 13,259,514 | 10.0% | EDGAR |
| SC 13G/A | 2024-02-12 | Artisan Partners Limited Partnership | HALOZYME THERAPEUTICS, INC. | 6,689,058 | 5.1% | EDGAR |
| SC 13G/A | 2024-02-01 | Invesco Ltd. | HALOZYME THERAPEUTICS, INC. | 2,816,427 | 2.1% | EDGAR |
| SC 13G/A | 2024-01-23 | BlackRock Inc. | HALOZYME THERAPEUTICS, INC. | 18,629,818 | 14.1% | EDGAR |
| SC 13G/A | 2023-06-09 | VANGUARD GROUP INC | HALOZYME THERAPEUTICS, INC. | 13,528,630 | 10.3% | EDGAR |
| SC 13G/A | 2023-02-10 | Artisan Partners Limited Partnership | HALOZYME THERAPEUTICS, INC. | 7,140,953 | 5.3% | EDGAR |
| SC 13G/A | 2023-02-10 | BlackRock Inc. | HALOZYME THERAPEUTICS, INC. | 19,196,061 | 14.2% | EDGAR |
| SC 13G | 2023-02-10 | Invesco Ltd. | HALOZYME THERAPEUTICS, INC. | 7,036,951 | 5.2% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | HALOZYME THERAPEUTICS, INC. | 13,303,847 | 9.8% | EDGAR |
| SC 13G/A | 2023-01-26 | BlackRock Inc. | HALOZYME THERAPEUTICS, INC. | 18,214,071 | 13.6% | EDGAR |
| SC 13G | 2023-01-20 | BlackRock Inc. | HALOZYME THERAPEUTICS, INC. | 18,214,071 | 13.6% | EDGAR |
| SC 13G/A | 2022-12-12 | VANGUARD GROUP INC | HALOZYME THERAPEUTICS, INC. | 13,542,589 | 10.0% | EDGAR |
| SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | HALOZYME THERAPEUTICS, INC. | 13,495,913 | 9.6% | EDGAR |
| SC 13G/A | 2022-02-04 | Artisan Partners Limited Partnership | HALOZYME THERAPEUTICS, INC. | 9,505,768 | 6.8% | EDGAR |
| SC 13G/A | 2022-01-28 | BlackRock Inc. | HALOZYME THERAPEUTICS, INC. | 19,439,863 | 13.8% | EDGAR |
| SC 13G/A | 2021-02-12 | BB BIOTECH AG | HALOZYME THERAPEUTICS, INC. | 3,970,000 | 2.9% | EDGAR |
| SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | HALOZYME THERAPEUTICS, INC. | 13,149,703 | 9.7% | EDGAR |
| SC 13G/A | 2021-02-10 | Artisan Partners Limited Partnership | HALOZYME THERAPEUTICS, INC. | 10,284,136 | 7.6% | EDGAR |
| SC 13G/A | 2021-01-26 | BlackRock Inc. | HALOZYME THERAPEUTICS, INC. | 18,481,307 | 13.7% | EDGAR |
| SC 13G | 2020-12-08 | BlackRock Inc. | HALOZYME THERAPEUTICS, INC. | 18,684,130 | 13.8% | EDGAR |